JGC
NUVA

J. Goldman & Co’s NuVasive, Inc. NUVA Stock Holding History

J. Goldman & Co’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-164,329
Closed -$6.79M – 526
2023
Q1 		$6.79M Sell
164,329
-102,550
-38% -$4.39M 0.27% 110
2022
Q4 		$11M Buy
+266,879
New +$10.8M 0.54% 57
2020
Q3 		– Sell
-61,106
Closed -$3.4M – 414
2020
Q2 		$3.4M Buy
61,106
+29,833
+95% +$1.73M 0.21% 121
2020
Q1 		$1.58M Sell
31,273
-112,248
-78% -$7.53M 0.19% 117
2019
Q4 		$11.1M Buy
143,521
+5,374
+4% +$379K 0.8% 32
2019
Q3 		$8.76M Buy
+138,147
New +$8.63M 0.66% 52

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

J. Goldman & Co's NUVA Position: Q2 2023 in Review

J. Goldman & Co sold out of NuVasive, Inc. (NUVA) in Q2 2023, closing a stake of 164,329 shares — an estimated $6.79M sold.

J. Goldman & Co first reported a position in NUVA in Q3 2019 and held it in 6 quarters. The position peaked at $11.1M in Q4 2019. 228 funds tracked by Wall St. Rank hold NUVA as of Q2 2023.

  • J. Goldman & Co reported no remaining NuVasive, Inc. position as of Q2 2023 after selling out during the quarter.
  • J. Goldman & Co sold 164,329 NuVasive, Inc. shares in Q2 2023, an estimated $6.79M.
  • J. Goldman & Co first reported a position in NuVasive, Inc. in Q3 2019 and held it in 6 quarters.
  • J. Goldman & Co's NuVasive, Inc. position peaked at $11.1M in Q4 2019.
  • 228 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2023.

Based on J. Goldman & Co's 13F filing for Q2 2023, filed 14 Aug 2023.